Valence8 US »

Soleno Therapeutics shares owned by Valence8 US

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Valence8 US from 13F filings

Historical chart of Valence8 US investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Valence8 US consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Valence8 US

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.1M 22k 50.49

More positions owned by Valence8 US

Ishares Tr Msci Usa Qlt Fct (QUAL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Msci Intl Qualty (IQLT)
Ishares Tr Eafe Value Etf (EFV)
Vanguard Index Fds Value Etf (VTV)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Ishares Tr Msci Uk Etf New (EWU)
Ishares Msci Jpn Etf New (EWJ)
Astrazeneca Sponsored Adr Call Option (AZN)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Amgen Put Option (AMGN)
Soleno Therapeutics (SLNO)
Insmed Com Par $.01 Call Option (INSM)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Bristol Myers Squibb (BMY)

View all positions for Valence8 US

Top funds holding Soleno Therapeutics

Carlyle
Henderson Group
Nantahala Capital Management
Perceptive Advisors
BlackRock
BlackRock
Vanguard Group
T. Rowe Price Associates
Commodore Capital
State Street Corporation
Alyeska Investment Group
Sofinnova Ventures
Frazier Life Sciences Management
Vestal Point Capital
Holocene Advisors

View all funds holding Soleno Therapeutics